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JAs a discipline, preventive medicine has traditionally been described to encompass primary,
secondary, and tertiary prevention. The ﬁelds of preventive medicine and public health share the
objectives of promoting general health, preventing disease, and applying epidemiologic techniques
to these goals. This paper discusses a conceptual approach between the overlap and potential
synergies of integrative medicine principles and practices with preventive medicine in the context of
these levels of prevention, acknowledging the relative deﬁciency of research on the effectiveness of
practice-based integrative care. One goal of integrative medicine is to make the widest array of
appropriate options available to patients, ultimately blurring the boundaries between conventional
and complementary medicine. Both disciplines should be subject to rigorous scientiﬁc inquiry so
that interventions that are efﬁcacious and effective are systematically distinguished from those that
are not. Furthermore, principles of preventive medicine can be infused into prevalent practices in
complementary and integrative medicine, promoting public health in the context of more
responsible practices. The case is made that an integrative preventive approach involves the
responsible use of science with responsiveness to the needs of patients that persist when conclusive
data are exhausted, providing a framework to make clinical decisions among integrative therapies.
(Am J Prev Med 2015;49(5S3):S230–S240) & 2015 American Journal of Preventive Medicine. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionThedividing line between preventive medicine andpublic health practice is far from distinct, as isthat between prevention and treatment. The
purview of preventive medicine has traditionally been
described to encompass primary, secondary, and tertiary
prevention in the construct usually attributed to Leavell
and Clark.1 Others have expanded on this construct;
quaternary prevention focuses on reducing overmedical-
ization and protecting patients from unnecessary or
excessive invasive interventions,2 whereas primordial
prevention focuses on the alteration of societal (i.e.,
environmental, economic, social, behavioral, cultural)
structures that affect disease risk.3
This paper discusses a conceptual approach between
the overlap and potential synergies of integrative medicine
and preventive medicine in the context of these levels of
prevention, and represents an update of a prior paper on
this topic commissioned by the then IOM (now National
Academy of Medicine), and placed in the public domain.4e School of Medicine, New Haven, Connecticut; and 2Yale
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is an open access article under the CC BY-NCIntegrative Medicine and Nomenclature
Integrative medicine, a concept developed over the past few
decades,5 refers to the fusion—by various means, and to
varying degrees—of conventional medical practice and
some of the practices that fall under the complementary
and alternative medicine (CAM) rubric.5,6 Integrative
medicine thus offers, in theory at least, the opportunity to
combine the “best” of the conventional healthcare system
and practices and providers commonly considered to be
CAM,7 and thereby produce better outcomes, measured in
terms of symptom relief, functional status, patient satisfac-
tion, and perhaps cost effectiveness.8 Integrative medicine is
necessarily “holistic” in the sense that somatic, emotional,
and spiritual health are considered integral to overall
health.9 These deﬁnitions are inherently problematic; what
exactly comprises spiritual health, or whether this is the
appropriate realm of the physician, is debated.10,11 Further,
integrative medicine advocates are accused of creating a
forced dichotomy between an idealized patient-centered
biopsychosocial approach12 incorporating CAM and “good
conventional medicine.”13 A rationale for integrative med-
icine depends largely on a rationale for CAM, as CAM
tends to be the limiting element in efforts to advance
integrative care.
The term CAM is used to describe diverse medical
practices not routinely taught in mainstream medical
education.6 “Alternative” denotes that such practices aren Journal of Preventive Medicine  Published by Elsevier Inc. This
-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of mainstream health care. “Complementary” implies
that these practices are supplemental to conventional
health care. The discrepancy in suggesting that such
practices are both alternative and complementary to
mainstream care has been noted.4,14,15
Such challenges to the nomenclature notwithstanding,
CAM has been the most widely used academic appellation,
its primacy conveyed by its incorporation into the title of
the NIH National Center for Complementary and Alter-
native Medicine, recently renamed to the National Center
for Complementary and Integrative Health, acknowledg-
ing that pure “alternative medicine” is rare, and that
“integrative” better conveys prevalent practice patterns.6
Despite institutionalization of this terminology, this broad-
based categorization overlooks necessary nuance. “CAM”
and “integrative” thus encompass practices and practi-
tioners inside and outside of the mainstream, as well as
approaches rooted in historic or cultural contexts, uncon-
ventional diagnostics and diagnoses, new and untested
approaches, and off-label use of conventional therapies.
These terms also encompass therapies and approaches that
have historically been embraced by CAM clinicians but are
recently becoming mainstream (such as some mind–body
therapies and interest in the human microbiome beyond
gastrointestinal conditions).16–18
Interest in and use of complementary health
approaches has remained constant in recent years in
adults19 and children20 after a rise in use between 1990
and 1997.21 One third of the adult population19 and 12%
of children20 have used at least one CAM therapy. The
majority of patients seek CAM approaches to comple-
ment rather than substitute for conventional care most
often for pain and chronic musculoskeletal conditions.22
Americans spent an estimated $33.9 billion on CAM
services in 2007.23 The use of CAM is more prevalent
among female, better-educated, higher-income popula-
tions21,22 with chronic and degenerative condi-
tions.20,24,25 Predictors of CAM use include a holistic
philosophical orientation to health and life, a chronic
health condition, environmentalism, feminism, and an
interest in spirituality and personal growth psychology.25
Other studies show a relationship to health-promoting
lifestyle choices: Regular physical activity, infrequent to
moderate alcohol consumption, and being a former
smoker are associated with CAM use.26 Although
research ﬁndings vary, common reasons that people
choose CAM include dissatisfaction with conventional
care; a desire to avoid side effects of conventional
medicine and treatments; an interest in and greater
knowledge of how nutritional, emotional, and lifestyle
factors affect health; and a broader focus on disease
prevention and overall health.21,24,25November 2015Despite prevalent CAM usage, fewer than 40% of
CAM patients disclose this information to their main-
stream physicians, indicating an important disconnect
between patient preferences and comfort in sharing these
views.21,25,27–30 This salient deﬁciency in provider–
patient communication28–30 might reﬂect mistrust, dis-
satisfaction with the conventional healthcare system,25 or
a response to the perceived receptivity of conventional
providers.4
Therefore, a case may be made to responsibly guide
patients in CAM therapies based on interest and in
accordance with scientiﬁc evidence. Because this guid-
ance should by no means supplant conventional treat-
ments, an argument for an integrative approach emerges:
Patients should ideally receive expert guidance across the
availability of treatments that may result in improved
health.4Integrative Medicine Across the Prevention
Spectrum
As behavioral and lifestyle choices account for the
majority of premature mortality in the U.S.,31 target-
ing these areas can potentially provide the greatest
beneﬁt. In 2010, the leading cause of death in the U.S.
was tobacco use, which resulted in some 435,000
deaths, or 18.1% of total deaths. Closely following
was diet and lack of physical activity, resulting in
400,000 deaths.31
The following sections discuss the potential for inte-
grative medicine across the prevention spectrum. By and
large, the effectiveness of integrative approaches in health
promotion or disease prevention is not fully elucidated;
data derived from direct tests of integrative care models
are promising but preliminary.32–35Integrative Medicine in Primary Prevention
Among the means to promote lifestyle change is model-
ing (i.e., being an exemplar of) healthy behavior, notably
diet and physical activity. Physicians that practice healthy
behaviors tend to emphasize these behaviors in patient
care; consequently, patients of these physicians generally
receive stronger, more pronounced, and more speciﬁc
advice regarding lifestyle change.36,37 Physicians who
exercise regularly are more likely to counsel their patients
to do so; nonsmokers are more likely to emphasize the
risks of smoking.38
A number of integrative health organizations encour-
age members to model healthy lifestyle behaviors,
including the Academy of Integrative Health & Medi-
cine39 and the American Association of Naturopathic
Physicians.40 Among some integrative health educational
Ali and Katz / Am J Prev Med 2015;49(5S3):S230–S240S232institutions, a culture of wellness exists, where healthy
food choices are readily (if not exclusively) available and
faculty model healthy behaviors.
Furthermore, a number of CAM whole systems con-
sider dietary habits and therapeutic nutrition as a
cornerstone of health, including Traditional Chinese
Medicine,41 Ayurveda,42,43 and naturopathy.40,44 Some
dietary guidance is consistent with current mainstream
recommendations for chronic disease prevention,45
whereas some traditional recommendations conﬂict.
Challenges (and opportunities) also exist in synergiz-
ing primary prevention with integrative healthcare. A
sizable proportion of patients oriented toward CAM tend
to be skeptical of preventive interventions, especially
childhood vaccination.46,47 Anti-vaccine views48 and
increases in vaccine-preventable illnesses are associated
with care from CAM providers.49 An evidence-based
integrative approach in the context of “holistic preven-
tion,” emphasizing the patient–provider relationship,50
with a sympathetic understanding of parental concerns
can potentially increase immunization rates in parents
that would otherwise be mistrustful of more-
conventional clinicians,46 thus protecting public health
in the context of providing care that is responsive to the
needs of CAM-oriented patients.Secondary Prevention and Integrative Medicine
Integrative medicine has the potential to improve rates of
screening and uptake of preventive services through an
emphasis on a strong therapeutic alliance, prevention,
teaching, interprofessional, and holistic care.51 Nation-
ally, screening rates for preventive services are consid-
erably lower than ideal52; much of the blame can be
placed on lack of emphasis and training in health
promotion and disease prevention as well as the burdens
of a healthcare system that constrain primary care visits
to suboptimal levels.53–55 Abbreviated primary care
encounters, coupled with barriers to access, tend to
compromise continuity of care as well.55
As prevention and population health activities occur in
almost all healthcare settings,56 clinicians can potentially
improve screening rates and utilization of preventive
services and enhancing risk-reduction efforts for chronic
diseases with strong diet and lifestyle associations,
namely, cardiovascular disease, diabetes, and certain
cancers.57 Despite this potential, the authors are not
aware of evidence of enhanced screening and preventive
services in integrative medicine.
Many CAM approaches have demonstrated promise in
treating early disease or risk factors such as improving the
lipid proﬁle,58 reducing inﬂammation,59 controlling
serum glucose, and reducing blood pressure.60–64 By usingthese in combination with comprehensive lifestyle change,
mind–body interventions, and mainstream preventive
recommendations65 with a strong therapeutic alliance,
the potential to improve outcomes rationally follows.
In certain instances, an integrative approach can be
used to enhance adherence with conventional therapies,
such as using the nutritional supplement coenzyme Q10
to reduce statin-induced myopathy66 (though other
studies demonstrate a lack of beneﬁt)67; probiotics to
reduce antibiotic-associated diarrhea68–70; licorice and its
derivatives to potentiate the effects of cortisone71 and
reduce non-steroidal anti-inﬂammatory drug–associated
gastropathy72; and a variety of integrative approaches to
improve quality of life and adverse effects associated with
cancer chemotherapy.73Tertiary Prevention and Integrative Medicine
Many lifestyle programs demonstrate effectiveness for
tertiary prevention of cardiometabolic disease.74–76
Though aspects of such programs have now arguably
been conventionalized (i.e., diet and lifestyle), the blend-
ing of lifestyle, dietary supplements, and mind–body
interventions is certainly representative, if not diagnostic,
of integrative care.4
Integrative healthcare approaches for chronic disease
can improve functionality, reduce morbidity, improve
quality of life, and directly inﬂuence disease processes.
The quality of evidence for CAM therapies is mixed for
treating chronic conditions with signiﬁcant public health
impact.77 Nutritional supplements such as ﬁsh oil,78
chromium,79 alpha-lipoic acid,80 herbal medicines,81 and
mind–body techniques82 have been used to treat Type 2
diabetes mellitus. Hyperlipidemia can be treated with
therapeutic diets consisting of functional foods,83,84 nutri-
tional supplements, and herbal medicines.58 Manual thera-
pies such as massage can be useful for osteoarthritis,85 as
well as acupuncture,86 and nutritional and herbal supple-
ments.87 An anti-inﬂammatory diet,59,88 nutritional supple-
ments, manual therapies, and other CAM therapies have
shown promise in the management of rheumatoid
arthritis.89
The public health impact of obesity and its related
sequelae is unparalleled in the U.S., while the prevalence
is quickly rising throughout the rest of the world.90
Integrative medicine has the potential to add to obesity
prevention and control efforts by emphasizing nutrition,
stress reduction,91 and exercise.92 There also tends to be
an emphasis on dietary supplements, although the
scientiﬁc evidence underlying such recommendations
has long been suspect.93,94
At least 13% of outpatient visits are attributable to
medically unexplained symptoms95,96 (also known aswww.ajpmonline.org
Table 1. Beneﬁt and Risk Ratio and Selection of Therapiesa
Effective
Safe Yes No
Yes Use Tolerate
No Monitor Avoid
aFrom Cohen and Eisenberg128
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drome, irritable bowel syndrome, ﬁbromyalgia, chronic
Lyme disease,97 and chronic unexplained pain,98 which
are often complicated by concurrent psychological dis-
tress and strong emotions.97,99 Mainstream care for
patients with these conditions is often frustrating, usually
resulting in extensive diagnostic workups and signiﬁcant
iatrogenic complication rates.95,100 In one study, a
majority of primary care physicians described attitudes
toward patients as negative and dismissing,101 and
another study found substantial discordance between
patient and physician treatment goals. 102
As is true of many health conditions that are poorly
understood and often resistant to conventional treat-
ments, medically unexplained conditions often compel
patients to seek CAM.97,103–107 The holistic nature of
integrative care, with an emphasis on mind–body med-
icine, often results in recommendations incorporating
psychological and somatic therapies.9,108,109
CAM therapies for pain control vary in demonstrated
efﬁcacy, spanning mind–body therapies such as medita-
tion110,111 and biofeedback,112 to tai chi,113 acupuncture,
yoga, hypnosis, chiropractic, nutritional interventions,114
herbal medicines, massage,85 or combinations thereof.115
In recent years, a number of whole-practice outcomes
studies demonstrate beneﬁt of integrative approaches,
particularly in chronic pain,32,34,35,116–118 Type 2 diabetes,33
and cardiovascular risk markers.119 These ﬁndings suggest
public health beneﬁts as well as possible cost savings.8,119
Stress and Mind–Body Medicine
Integrative medicine tends to emphasize the importance
of psychological stress and its impact on overall health.51
The evidence is robust and broad-based; psychological
stress leads to poorer health outcomes—encompassing
infectious and chronic disease, morbidity and mortality,
and developing illness as well as recovery.120
Psychological states can also be beneﬁcial; the presence
of “positive emotions” has been shown to predict better
health and outcomes.121–123 Personality aspects such as
commitment to self, an attitude of concern for the
environment, a sense of meaningfulness, and an internal
locus of control are all associated with decreased illness in
high-stress environments.124
Contextual factors and the therapeutic relationship are
important factors in the overall effectiveness of a therapy,
especially with subjective outcomes such as in chronic
pain syndromes,125,126 and perhaps stronger with CAM
approaches associated with elaborate rituals and distinct
contexts.127 There is an ethical imperative to provide
therapeutic options that are safe and effective for
symptomatic relief, with appropriate informed consent,November 2015without endorsing approaches that are unsafe or ineffec-
tive.128 There is an emerging literature on the psycho-
biology of the placebo effect, with clinically signiﬁcant
effects demonstrated in a variety of contexts.127,129,130
Intentional use of placebo in clinical practice is rou-
tine,131 with complex ethical implications.127
Integrative medicine offers a framework that incorpo-
rates psychoemotional factors as integral to overall health
with the resultant emphasis on mind–body therapies.132
These factors are often perceived to be overlooked in
conventional clinical practice andmedical education,133–136
or challenging to practically address in hurried medical
visits resulting from ﬁnancial constraints of the current
health delivery system.53–55
Evidence and Integrative Medicine
As integrative medicine often incorporates approaches
outside of mainstream care where evidence is weak or
speculative, a systematic method in addressing “uncon-
ventional therapies” is warranted.4 Where strong evi-
dence supporting a particular approach exists, that
should be recommended in preference to others. The
more ambiguous it is as to which might be the most
appropriate therapeutic choice, the more important it is
to consider a hierarchy of evidence, incorporating safety,
effectiveness, alternatives, and the evidence supporting
each Tables 1 and 2). For some medically unexplained
syndromes, such as ﬁbromyalgia or chronic fatigue
syndrome, a deﬁnitive therapy does not exist, and the
best available treatments are those safe and possibly
effective. Integrative medicine expands patient options at
this end of the evidence hierarchy, where options are
generally most needed. Any therapy that a patient refuses
to use is ineffective, regardless of the evidence supporting
its use.4
A common framework to assess the clinical appropri-
ateness of a particular CAM intervention has been
published in multiple venues.128,137,138 Therapies that
are both safe and effective are generally recommended,
whereas those that are unsafe and ineffective are avoided
and discouraged. Areas where either (but not both) safety
or efﬁcacy is questioned should be approached with
Table 2. The Clinical Applications of Research Evidence Constructa
Safety Efﬁcacy Science
Other therapeutic
options
Patient
preference
Cost /
accessibility
Utilization frequency of
treatment in question
High High Decisive None that is
superior
Prefers
recommended
approach
Not a
concern
Always
Probable Possible Unclear None/few Anything that will
work
Needs
consideration
Often
Low Low Absent/
opposed
Many that are
superior
Anything that will
work
Prohibitive Never
aAdapted and expanded from Katz and Ali.4
Ali and Katz / Am J Prev Med 2015;49(5S3):S230–S240S234caution. A rational expectation of beneﬁt, based on weak
clinical trial evidence or biological plausibility, may be
desirable in cases where more evidence-based treatment
options are unavailable or undesirable, or when patient
preference drives the consideration of a particular
intervention. Table 1 illustrates this decision framework.
The authors4 have also developed a similar framework
to guide clinical recommendations in the context of
indeﬁnite research. The expanded Clinical Applications
of Research Evidence construct, in Table 2, highlights the
practical, and practice-oriented, implications of this
interface. These frameworks serve as guides to system-
atically assess treatment options; clearly, clinical judg-
ment is much more nuanced. Furthermore, there may be
challenges in implementing an evidence-based frame-
work for providers that believe therapeutic choice is
intuitive and uncompromisingly individualized.139,140
This framework suggests that clinical application of
“evidence” depends on six considerations: the relative
safety of a given intervention; its relative effectiveness;
the quality and quantity of the supporting evidence; the
availability of other treatment options for the condition;
cost/accessibility (including insurance coverage, out-of-
pocket expense, practicality, availability of reliable pro-
viders); and patient preferences. When a treatment
approach is unsafe, ineffective, poorly supported by
science, less effective than other options, cost prohibitive,
and not uniquely compatible with patient preference, it
should never be used. When a treatment is safe, effective,
supported decisively by science, better than any other
therapeutic option, readily accessible, and preferred by a
patient, it should always be used. Challenges occur when
options reside in between, such as when the approaches
supported by the best science have all been tried, and
have all failed. What remains is a treatment that is
apparently safe, possibly effective, cost neutral, and
desired by the patient, but not deﬁnitively supported by
the available research evidence.4
When evaluating any potential clinical intervention,
there is an implicit (or explicit) assessment of risk versusbeneﬁt. Efﬁcacy is generally the major component of the
beneﬁt assessment (but not the only beneﬁt; for example,
psychological beneﬁt can occur even in the absence of
other clinical effects), whereas safety concerns are the
primary risk (but not the only risk; for example, there is
economic harm when using a safe but ineffective
intervention).Conclusions
The overlap of integrative medicine with preventive
medicine is noteworthy. At the level of primary pre-
vention, a number of approaches can contribute to
health promotion. Minimally, these encompass lifestyle
counseling, dietary guidance, stress mitigation techni-
ques, interventions to improve sleep quality, and use of
natural products for health promotion. At the level of
secondary prevention, approaches such as stress man-
agement and lifestyle interventions are germane, as are
interventions that facilitate use of conventional therapies
for risk attenuation. At the level of tertiary prevention,
the full range of complementary health approaches
pertain to such goals as pain management, symptom
control, stress relief, disease management, and risk
reduction.
To some extent, a conventional medical system that
has emphasized the diagnosis and treatment of disease
with ever-increasing degrees of specialization has margi-
nalized both preventive medicine and the holistic view
that is central to integrative medicine. The importance of
disease prevention/health promotion is gaining increas-
ing recognition, due in part to economic forces molding
the evolution of modern health care.141–144
As integrative medicine tends to be philosophically
aligned toward environmentalism25 and social justice,145
as well as being particularly concerned with iatrogenesis
(adverse effects of medical treatment),146 the interface of
integrative medicine and primordial and quaternary
prevention becomes apparent. Integrative medicine thus
offers the promise of more-expansive means to achievewww.ajpmonline.org
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the challenges of assessing evidence across that broader
expanse.
With patients increasingly interested in complemen-
tary and integrative approaches and conventional practi-
tioners often uninformed or reticent, a system of
unintegrated or, worse, disintegrated health care prevails
in the U.S. Some conventional physicians actively dis-
courage the use of CAM wholesale, without considering
the differences in approaches or practitioners—or the
potential value of integrative care. CAM-oriented practi-
tioners may be just as apt to discourage the use of
standard preventive interventions of conventional med-
icine, citing its reliance on pharmaceuticals and invasive
procedures, a failure to respect nature, a systemic lack of
compassion and patient centeredness, and ﬁnancial
conﬂicts of interest.147,148 It is noteworthy that conﬂicts
of interest (ﬁnancial and non-ﬁnancial) and ethical
challenges are prevalent in a number of CAM arenas
such as providers proﬁting from dietary supplement sales
and laboratory testing.149–151 There is real danger here of
patients toppling into the divide, with attendant squan-
dering of the potential for disease prevention and health
promotion.
The Integrative Medicine in Preventive Medicine
Education project was designed to introduce preventive
medicine residents to integrative medicine to enhance
the education and practice of preventive medicine,152
implying a unidirectional positive inﬂuence of integrative
medicine. This is also an opportune time to encourage a
bidirectional exchange of ideas where preventive medi-
cine can enhance integrative medicine. In particular,
fundamentals of preventive medicine training and prac-
tice—biostatistics, epidemiology, research into causes of
disease in population groups, the practice of prevention
in clinical medicine, and planning and evaluation of
health services153—can improve aspects of CAM and
integrative medicine in such areas as childhood vaccines
and encourage the critical evaluation of prevalent prac-
tices. Indeed, recent national initiatives to limit pharma-
ceutical industry inﬂuence in medical education
(PharmFree),154 better disclosure of ﬁnancial conﬂicts
of interest (Sunshine Act),155 and purging low-value
practices from medical specialties (Choosing Wisely)156
can serve as models to improve CAM and integrative
health care. Implementing U.S. Food and Drug Admin-
istration good manufacturing practices for dietary sup-
plements can mitigate risk of contamination and poor
quality control.157 Incorporating emerging ﬁndings from
clinical and neurobiological158 research of contextual and
placebo effects can enhance the delivery159 and under-
standing of some CAM approaches. Overall, the appli-
cation of preventive medicine principles and recentNovember 2015quality improvement initiatives can strengthen integra-
tive medicine in the context of a healthcare system
moving to value-based care.144
Recent outcomes research on models (or “whole
systems”) of integrative care32–35,116–118 demonstrate
promise and innovation, as well as potential cost
savings,8,119 despite a lack of large-scale funding160,161
and methodologic challenges.162–164 Practice-based
research networks of integrative medicine centers are
now adding to the literature on community effectiveness
of integrative medicine for chronic pain116 and cancer
care.165 Initiatives in integrative practices in underserved
communities166–168 demonstrate a public health orienta-
tion beyond the more educated and afﬂuent demographics
historically associated with CAM. Furthermore, the
Patient-Centered Outcomes Research Institute, established
by Congress in the Patient Protection and Affordable Care
Act of 2010,169 is focused on patient-centered comparative
clinical effectiveness research and includes explicit stipula-
tions for research on “integrative health practices.”169
Relevant PCORI-funded research focused on chronic pain
in underserved communities include studies in acupunc-
ture170 and integrative group visits.171 Some posit that
these emerging ﬁndings can inﬂuence the current health-
care system to be both more value driven and more aligned
to integrative principles.172
The ultimate goal of integrative medicine should be to
make the widest array of appropriate options available to
patients. Appropriateness should be predicated on fun-
damental considerations that pertain equally to conven-
tional and CAM practice: treatment safety and treatment
effectiveness. Treatment safety and treatment effective-
ness must, in turn, be interpreted in light of the available
evidence.
Evaluating the current state of integrative medicine
and preventive medicine leads to a number of funda-
mental research questions that can address essential gaps.
The role of integrative medicine in areas germane to
primary and secondary prevention needs to be better
assessed in terms of rates of uptake of clinical preventive
services, as well as the ability to demonstrably improve
diet, physical activity, and smoking-cessation efforts. The
question of whether integrative clinicians model healthy
behavior and inﬂuence their patients in comparison to
other clinicians is relevant, as well as cost-effectiveness
studies of integrative practices in high-priority areas such
as pain management and adjunctive cancer care.173
But even in the absence of evidence, health care is not
advanced by failing to adequately treat symptoms, engage
patients in a therapeutic alliance, control disease progres-
sion, or produce satisfaction.4 The simple argument
supporting integrative care is that modern medical science
and knowledge, despite profound successes, comprises
Ali and Katz / Am J Prev Med 2015;49(5S3):S230–S240S236far less than patient need. Integrative care is not a
comprehensive solution, but does expand the array of
patient options, and can increase the likelihood of success
that can be assembled across the stages of prevention.4Publication of this article was supported by the Health
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